| P2093 | author name string | Ramazan Sari | |
| | Erkan Coban | |
| P2860 | cites work | Mechanism of action of fibrates on lipid and lipoprotein metabolism | Q28288187 |
| | Fibrates, dyslipoproteinaemia and cardiovascular disease | Q28370659 |
| | Effects of comicronised fenofibrate on lipid and insulin sensitivity in patients with polymetabolic syndrome X. | Q34511337 |
| | Effects of fibrates on serum metabolic parameters. | Q34871191 |
| | Inflammatory bio-markers and cardiovascular risk prediction | Q34941391 |
| | High sensitivity C-reactive protein: an emerging role in cardiovascular risk assessment | Q34973446 |
| | Peroxisome proliferator-activated receptors and the cardiovascular system | Q35173859 |
| | High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention | Q35209311 |
| | Obesity-induced inflammatory changes in adipose tissue. | Q40348859 |
| | Efficacy of fenofibrate and simvastatin on endothelial function and inflammatory markers in patients with combined hyperlipidemia: relations with baseline lipid profiles | Q40550294 |
| | C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women | Q40608305 |
| | C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction | Q40857092 |
| | Effect of ciprofibrate on C-reactive protein and fibrinogen levels | Q44003335 |
| | Fenofibrate lowers abdominal and skeletal adiposity and improves insulin sensitivity in OLETF rats | Q44090287 |
| | Gemfibrozil reduces release of tumor necrosis factor-alpha in peripheral blood mononuclear cells from healthy subjects and patients with coronary heart disease | Q44451316 |
| | Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators | Q47877643 |
| | Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. | Q50950290 |
| | Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus. | Q51556988 |
| | Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. | Q51610700 |
| P433 | issue | 3 | |
| P921 | main subject | obesity | Q12174 |
| P304 | page(s) | 343-349 | |
| P577 | publication date | 2004-08-01 | |
| P1433 | published in | Endocrine Research | Q5376305 |
| P1476 | title | The effect of fenofibrate on the levels of high sensitivity C-reactive protein in dyslipidemic obese patients | |
| P478 | volume | 30 | |